|
End-of-day quote
Toronto S.E.
22:59:45 18/03/2019 +03
|
5-day change | 1st Jan Change | ||
| 1.880 CAD | +1.62% |
|
+1.62% | +106.59% |
| 14/05/19 | Emblem Corp. Reports Earnings Results for the Full Year Ended December 31, 2018 | CI |
| 19/03/19 | Emblem Corp.(TSXV:EMC) dropped from S&P/TSX Venture Composite Index | CI |
| Market Cap | 248M 218M 206M 188M 351M 23.79B 354M 2.47B 954M 12.16B 932M 912M 39.13B | P/E 2017 |
-16.3x | P/E 2018 | -4.48x |
|---|---|---|---|---|---|
| Enterprise Value | 219M 193M 182M 166M 310M 21.01B 313M 2.18B 842M 10.73B 823M 805M 34.55B | EV / Sales 2017 |
72,352,077x | EV / Sales 2018 | 10,915,686x |
| Free-Float |
98.36% | Yield 2017 * |
-
| Yield 2018 | - |
| 1 day | +1.62% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tricia Symmes
CEO | Chief Executive Officer | - | - |
Nick Dean
CEO | Chief Executive Officer | - | 01/12/2017 |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John H. Stewart
BRD | Director/Board Member | - | - |
Jeffrey Fineberg
BRD | Director/Board Member | - | - |
Terry Johnson
BRD | Director/Board Member | - | 06/12/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.62% | +1.62% | - | - | 0 | |
| -2.90% | -2.31% | -12.68% | -5.48% | 13.26B | |
| -1.14% | +0.52% | -31.75% | -56.94% | 4.77B | |
| -1.95% | -0.24% | -5.11% | -6.23% | 4.29B | |
| -2.07% | -0.39% | -4.24% | -34.85% | 3.77B | |
| -0.73% | +1.80% | -19.81% | -0.79% | 3.48B | |
| -0.65% | -3.10% | -1.89% | -6.69% | 3.35B | |
| -1.51% | -1.30% | -12.92% | -2.01% | 3.04B | |
| -1.09% | -0.07% | -20.48% | -18.24% | 2.24B | |
| -0.87% | +0.05% | -25.38% | -24.03% | 1.64B | |
| Average | -1.13% | -0.34% | -14.92% | -17.25% | 3.98B | |
| Weighted average by Cap. | -1.84% | -0.97% | -14.04% | -15.40% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 2.69 2.37 2.23 2.04 3.81 258.09 3.84 26.75 10.35 131.87 10.11 9.89 424.47 | 8.22 7.23 6.82 6.22 11.64 787.78 11.73 81.66 31.59 402.51 30.87 30.2 1.3K |
| Net income | -12.1M -10.63M -10.04M -9.15M -17.12M -1.16B -17.26M -120M -46.48M -592M -45.43M -44.44M -1.91B | -24.26M -21.32M -20.12M -18.34M -34.33M -2.32B -34.6M -241M -93.19M -1.19B -91.08M -89.1M -3.82B |
| Net Debt | -21.51M -18.91M -17.85M -16.26M -30.44M -2.06B -30.68M -214M -82.63M -1.05B -80.76M -79.01M -3.39B | -29.05M -25.53M -24.1M -21.96M -41.11M -2.78B -41.44M -289M -112M -1.42B -109M -107M -4.58B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- EMC Stock
Select your edition
All financial news and data tailored to specific country editions
